Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

NCT01446484 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

End-Stage Renal Disease
Kidney Failure

Interventions

BIOLOGICAL: CD4+CD25+CD127lowFoxP3+ T regulatory cells injection
DRUG: Alemtuzumab
DRUG: Mycophenolate mofetil
DRUG: Sirolimus
DRUG: Tacrolimus
DRUG: Cyclosporine
DRUG: Everolimus
PROCEDURE: Kidney transplantation

Sponsor

Pirogov Russian National Research Medical University

Collaborators

[object Object]